Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Multiple Myeloma
Sort By
Newest First
1 / 1
Small Biotechs
Five Small Biotechs to Watch: March 2025
David Alvaro, Ph.D.
Pharma's Almanac
PAO-02-25-NI-06
Feb 28, 2025
Multiple Myeloma
Janssen Reports Positive Results for DARZALEX® in Multiple Myeloma
Emilie Branch
Pharma's Almanac
PAO-M12-19-NI-006
Dec 13, 2019
Sutro Biopharma, Inc.
Multiple Myeloma
Sutro's STRO-001 Receives U.S. FDA Orphan Drug Designation for Treatment of Multiple Myeloma
Sutro Biopharma, Inc.
PR-M10-18-NI-049
Oct 15, 2018
OncoPep
Cancer Treatment
OncoPep Announces a Phase 1b Clinical Trial of Its Multi-Peptide Cancer Vaccine PVX-410 in Combination with Citarinostat for Smoldering Multiple Myeloma
OncoPep
PR-M08-18-NI-084
Aug 21, 2018
Janssen Pharmaceutical Companies
Positive Opinion
Janssen Receives Positive CHMP Opinion for Darzalex®▼ (daratumumab) as Frontline Treatment for Newly Diagnosed Patients with Multiple Myeloma
Janssen Pharmaceutical Companies
PR-M08-18-NI-007
Aug 02, 2018
Amgen
Collaboration
Amgen And MD Anderson Announce Collaboration To Accelerate Early Stage Treatments For Cancer
Amgen
PR-M06-18-NI-028
Jun 08, 2018
Janssen Pharmaceutical Companies
Janssen Announces Initiation of Phase 1b/2 Clinical Development Program Evaluating JNJ-68284528 CAR-T Cells for the Treatment of Multiple Myeloma
Janssen Pharmaceutical Companies
PR-M06-18-NI-005
Jun 01, 2018
1 / 1
